Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$194.09 - $276.37 $19,797 - $28,189
-102 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$245.33 - $277.77 $25,023 - $28,332
102 New
102 $27,000
Q4 2021

Jan 28, 2022

SELL
$236.63 - $276.44 $98,911 - $115,551
-418 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$248.9 - $280.09 $32,605 - $36,691
-131 Reduced 23.86%
418 $110,000
Q2 2021

Jul 28, 2021

SELL
$242.95 - $267.0 $53,206 - $58,473
-219 Reduced 28.52%
549 $142,000
Q1 2021

Apr 30, 2021

SELL
$221.01 - $248.82 $106,968 - $120,428
-484 Reduced 38.66%
768 $187,000
Q4 2020

Jan 27, 2021

SELL
$202.01 - $245.04 $428,867 - $520,219
-2,123 Reduced 62.9%
1,252 $306,000
Q3 2020

Oct 06, 2020

BUY
$177.77 - $215.81 $11,199 - $13,596
63 Added 1.9%
3,375 $703,000
Q2 2020

Jul 10, 2020

BUY
$144.67 - $207.03 $424,461 - $607,426
2,934 Added 776.19%
3,312 $596,000
Q1 2020

Apr 17, 2020

SELL
$126.5 - $225.1 $10,626 - $18,908
-84 Reduced 18.18%
378 $62,000
Q1 2019

Apr 24, 2019

BUY
$152.46 - $198.0 $32,169 - $41,778
211 Added 84.06%
462 $0
Q4 2018

Jan 31, 2019

BUY
$145.0 - $178.65 $36,395 - $44,841
251 New
251 $39,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.